Beam Therapeutics (NasdaqGS:BEAM) was named one of TIME’s 10 Most Influential Health & Life Science Companies of 2026. The recognition highlights Beam’s progress in base editing gene therapies and its ...

That is because scientists keen to achieve more precise control over an organism’s genetics are experimenting with a ...

Before Baby KJ was six months old, doctors at Children’s Hospital of Philadelphia injected a gene-editing therapy built for ...

Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling ...

Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...

A new prime assembly technique inserts DNA segments up to 11,000 base pairs into the genome, enabling correction of thousands ...

Eli Lilly’s latest attempt to strengthen its genetic medicine offering has seen the Big Pharma team up with Profluent to ...

Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...

A new platform identifies which genes drive particle assembly to engineer cells that yield more potent delivery vehicles.

Colossal Biosciences has announced it is in the genome-editing phase of its plan to resurrect the bluebuck, a South African antelope hunted to extinction around 1800. Using DNA from a museum specimen ...